FDA updates potential risks with liquid-filled intragastric balloonsThere were no deaths reported in the Orbera and ReShape post-approval studies; however, it should be noted that neither of the studies...
Apollo Endosurgery completes US post-approval ORBERA studyApollo Endosurgery has announced that the FDA has completed the review of the final Post-Approval Study (PAS) Report for the ORBERA...
GLP-1s associated with higher risk of major depression, increased risk for anxiety and an elevated risk for suicidal behaviour1 day ago